230 related articles for article (PubMed ID: 31009502)
21. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
22. [Effects of acute lymphoblastic leukemia children bone marrow mesenchymal stem cells on drug resistance of K562/A02 cell line].
Wang ZX; Yang ZM; Zou YW; Li MM; Chen FX; Zhong GY; Guan JM; Wei FG; Wu SZ; He ZT; Wu ZL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):19-23. PubMed ID: 21362214
[TBL] [Abstract][Full Text] [Related]
23. Glucosamine sulfate-induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL.
Wang Z; Liang R; Huang GS; Piao Y; Zhang YQ; Wang AQ; Dong BX; Feng JL; Yang GR; Guo Y
Apoptosis; 2006 Oct; 11(10):1851-60. PubMed ID: 16850161
[TBL] [Abstract][Full Text] [Related]
24. [Apoptosis mechanism in human chronic myelogenous leukemia K562 cells induced by tetra-arsenic tetra-sulfide].
Ye QD; Gu LJ; Zhao YX; Zhao JC; Chen WG; Zhang B; Jiang LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):759-63. PubMed ID: 16277837
[TBL] [Abstract][Full Text] [Related]
25. Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5.
Chen Y; Zhou Q; Zhang L; Zhong Y; Fan G; Zhang Z; Wang R; Jin M; Qiu Y; Kong D
Oncotarget; 2017 Apr; 8(17):28906-28921. PubMed ID: 28423649
[TBL] [Abstract][Full Text] [Related]
26. 2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562.
Pal P; Kanaujiya JK; Lochab S; Tripathi SB; Bhatt ML; Singh PK; Sanyal S; Trivedi AK
Proteomics; 2011 Apr; 11(8):1517-29. PubMed ID: 21360677
[TBL] [Abstract][Full Text] [Related]
27. [Study of apoptosis induced by indomethacin in chronic myeloid leukemia].
Tu C; Zhang G; Lu H
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):362-5. PubMed ID: 11721434
[TBL] [Abstract][Full Text] [Related]
28. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
29. Influence of human bone marrow mesenchymal stem cells on proliferation of chronic myeloid leukemia cells.
Zhang HM; Zhang LS
Ai Zheng; 2009 Jan; 28(1):29-32. PubMed ID: 19448412
[TBL] [Abstract][Full Text] [Related]
30. The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia.
Chen Y; Wang T; Du J; Li Y; Wang X; Zhou Y; Yu X; Fan W; Zhu Q; Tong X; Wang Y
Cell Physiol Biochem; 2018; 47(3):981-993. PubMed ID: 29843123
[TBL] [Abstract][Full Text] [Related]
31. K562 cell-derived exosomes suppress the adhesive function of bone marrow mesenchymal stem cells via delivery of miR-711.
Jiang YH; Liu J; Lin J; Li SQ; Xu YM; Min QH; Zhong QH; Sun F; Li J; You XH; Liao KL; Qin TY; Zhao C; Huang B; Wang XZ
Biochem Biophys Res Commun; 2020 Jan; 521(3):584-589. PubMed ID: 31677790
[TBL] [Abstract][Full Text] [Related]
32. The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells.
Grimaudo S; Meli M; Di Cristina A; Ferro A; Pipitone MR; Romagnoli R; Simoni D; Dieli F; Tolomeo M
Anticancer Drugs; 2013 Apr; 24(4):384-93. PubMed ID: 23370613
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow mesenchymal stem cells protect alveolar macrophages from lipopolysaccharide-induced apoptosis partially by inhibiting the Wnt/β-catenin pathway.
Li B; Zhang H; Zeng M; He W; Li M; Huang X; Deng DY; Wu J
Cell Biol Int; 2015 Feb; 39(2):192-200. PubMed ID: 25229877
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms in C-Phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562.
Subhashini J; Mahipal SV; Reddy MC; Mallikarjuna Reddy M; Rachamallu A; Reddanna P
Biochem Pharmacol; 2004 Aug; 68(3):453-62. PubMed ID: 15242812
[TBL] [Abstract][Full Text] [Related]
35. Differential responses of Bcl-2 family genes to etoposide in chronic myeloid leukemia K562 cells.
Fukumi S; Horiguchi-Yamada J; Nakada S; Nagai M; Ohno T; Yamada H
Mol Cell Biochem; 2000 Mar; 206(1-2):43-50. PubMed ID: 10839193
[TBL] [Abstract][Full Text] [Related]
36. Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia.
Li J; Xue L; Hao H; Han Y; Yang J; Luo J
Oncol Rep; 2012 Feb; 27(2):461-6. PubMed ID: 21993902
[TBL] [Abstract][Full Text] [Related]
37. Inhibiting AKT signaling pathway with cilostazol and meloxicam synergism for suppressing K562 cells in vitro.
Naderbar L; Pazhang Y; Rezaie J
J Biochem Mol Toxicol; 2022 Nov; 36(11):e23185. PubMed ID: 35920412
[TBL] [Abstract][Full Text] [Related]
38. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
[TBL] [Abstract][Full Text] [Related]
39. Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors.
Kuribara R; Honda H; Matsui H; Shinjyo T; Inukai T; Sugita K; Nakazawa S; Hirai H; Ozawa K; Inaba T
Mol Cell Biol; 2004 Jul; 24(14):6172-83. PubMed ID: 15226421
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo.
Chun-Guang W; Jun-Qing Y; Bei-Zhong L; Dan-Ting J; Chong W; Liang Z; Dan Z; Yan W
Eur J Pharmacol; 2010 Feb; 627(1-3):33-41. PubMed ID: 19857484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
